You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 084801


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 084801

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,071,402 Jan 5, 2032 Novartis MAYZENT siponimod
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR084801

Last updated: July 29, 2025

Introduction

Patent AR084801 pertains to a pharmaceutical invention registered in Argentina, a country with a substantial and evolving patent landscape. This analysis aims to dissect the patent’s scope and claims comprehensively, examine its landscape within Argentina and globally, and assess strategic implications for patent holders and competitors.

Patent Overview

AR084801 is classified under the local patent registry, indicating a focus on drug substances, formulations, or therapeutic methods. The patent’s primary objective appears to be enhancing drug efficacy, stability, or delivery, based on similar pharmaceutical patents in the region. Its filing date, priority claims, and expiration terms are essential for contextual understanding, although these specifics require access to the official patent documents.

Scope and Claims Analysis

Claims Structure and Definitions

The patent likely comprises a series of claims—independent and dependent—that define the scope of legal protection.

  • Independent Claims: Usually encompass the core inventive concept, such as a novel compound, a specific pharmaceutical formulation, or a unique method of manufacture or use.
  • Dependent Claims: Narrow the scope, adding specific features, polymorphs, concentrations, or application modalities.

Core Claim Focus

Preliminary examination suggests AR084801’s claims may revolve around:

  • Compound/Composition Claim: Possible claim on a novel chemical entity with specific structural features or modifications that improve pharmacological activity or reduce side effects.
  • Formulation Claim: Likely includes specific excipients, delivery systems (e.g., sustained-release), or stability enhancements.
  • Therapeutic Use Claim: Encompasses methods for treating particular diseases, aligning with patent conventions for method-of-use patents.

In essence, the scope hinges on how broadly or narrowly the claims are drafted:

  • Broad claims could potentially cover a wide range of analogs or formulations, offering stronger patent protection but facing higher invalidity risks.
  • Narrow claims restrict protection, providing precision but potentially easier to design-around.

Claim Validity and Limitations

Argentina follows the Patent Law No. 24,481, which emphasizes novelty, inventive step, and industrial application. Claims that lack novelty or inventive step—such as known molecules or obvious modifications—are susceptible to invalidation.

Patent examiners scrutinize whether the claimed invention demonstrates inventive ingenuity relative to prior art, such as existing patents in regional or international databases.

Comparison with International Patents

Argentina’s patent landscape includes filings from key pharmaceutical jurisdictions (USPTO, EPO, WIPO), impacting the scope of AR084801. If similar patents exist elsewhere, this could influence the patent’s enforceability and strategic value, especially considering the pharmaceutical patent landscape's harmonization efforts under the Patent Cooperation Treaty (PCT).

Patent Landscape in Argentina

Legal Framework and Patent Environment

Argentina’s patent system aligns with international standards, including compliance with the TRIPS agreement. The patent backlog can delay approval processes, and patent examiners perform substantive examination, notably focusing on novelty, inventive step, and industrial applicability.

Key Competitors and Patent Activity

Major pharmaceutical companies routinely file in Argentina to secure regional rights, with significant filings in therapeutic areas such as oncology, infectious diseases, and chronic conditions.

  • Local innovators also contribute, often focusing on proprietary formulations tailored to regional healthcare needs.
  • The presence of active pharma patent filings underpins a competitive landscape where patent validity and enforceability are critical for market exclusivity.

Research and Development Trends

Argentina’s biotech and pharmaceutical R&D landscape is growing, with increased patent filings reflecting innovation activity. The patenting of compounds and delivery methods suggests a strategic focus on technologically advanced therapeutics.

Strategic Patent Considerations

Strengths of AR084801

  • If claims are broad and well-drafted, the patent could secure notable commercial exclusivity within Argentina.
  • Potential for extension into regional markets, especially if claims align with international patents or derivatives are developed.

Risks and Challenges

  • Overly broad claims risk invalidation if prior art exists.
  • Narrow scope limits market exclusivity.
  • Patentability hurdles due to existing similar inventions in global databases.

Legal and Commercial Implications

  • Patent holders can leverage AR084801 for territorial exclusivity, licensing opportunities, or strategic partnerships in Argentina.
  • Competitors might seek to design around claims or challenge patent validity via legal proceedings.

Conclusion

Patent AR084801 embodies strategic intellectual property protection within Argentina’s pharmaceutical landscape. Its utility hinges on the precise drafting of claims, thorough patent prosecution to navigate regional prior art, and integration into a broader patent portfolio. Careful legal and market analysis is essential for optimizing its commercial value and safeguarding against infringement or invalidation.


Key Takeaways

  • Claim Clarity and Breadth: Precise, well-structured claims are vital to maximize protection while minimizing invalidity risks.
  • Regional Patent Strategies: Argentina’s patent environment is competitive; aligning filings regionally and internationally enhances enforcement potential.
  • Prior Art Vigilance: Patent landscape analysis must include global patent databases to anticipate overlaps or challenges.
  • Innovation and R&D Trends: Increased patent activity highlights Argentina’s expanding pharmaceutical innovation; staying ahead requires continuous monitoring.
  • Legal Enforcement: Strategic licensing, litigation, and patent defense are integral to capitalizing on patent AR084801’s value.

FAQs

Q1: How does Argentina’s patent examination process impact the scope of AR084801?
A1: Argentina conducts substantive examination emphasizing novelty and inventive step, which can limit overly broad claims or invalidate claims lacking distinct innovation.

Q2: Can AR084801 be challenged based on prior patents internationally?
A2: Yes, prior art from global patents can be used to challenge validity, especially if similar inventions exist, potentially leading to revocation or restriction of claims.

Q3: What strategies can strengthen the enforceability of AR084801?
A3: Narrowing claims to innovative features, conducting thorough prior art searches, and pursuing regional patent extensions enhance enforceability.

Q4: How does AR084801 compare with international patents in its technical scope?
A4: Without full claim details, the comparison depends on similarity to existing patents; broader claims may offer extensive protection but require careful examination against international prior art.

Q5: What are the critical considerations for licensing or commercialization of inventions protected by AR084801?
A5: Ensuring the validity and scope of patent claims, understanding regional market exclusivity, and navigating local legal procedures are crucial for successful licensing and commercialization.


References:

  1. Argentine Patent Law No. 24,481 (1996).
  2. Argentina Patent Office (INPI) Official Gazette.
  3. World Intellectual Property Organization (WIPO) Patent Database.
  4. EPO Patent Search Database.
  5. Regional patent filings and legal commentary (industry reports).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.